Source: Fox News
Summary
A study presented at the EADV Congress 2026 found that people taking GLP-1 medications for obesity or diabetes experience higher rates of nail detachment and hair loss compared to non-users. Two studies involving 575 users and 1,329 non-users found 39% of GLP-1 users reported nail detachment versus 9% of non-users. Hair loss affected 50% of users versus 34% of non-users. Researchers noted that weight loss alone did not explain the difference. The studies relied on self-reported data and could not confirm causation.
Our Reading
This guidance has been heard before.
GLP-1 drugs are linked to nail and hair issues, but causation is unclear.
Studies show higher rates of nail detachment and hair loss among users.
Weight loss alone does not explain the difference.
Researchers call for more studies to understand the causes and duration of these effects.
Medical advice changes, repeats, and rebrands itself.
Author: Evan Null
